首页> 外文期刊>Journal of Drug Delivery and Therapeutics >SCREENING OF DRUG RELATED PROBLEMS IN HIV PATIENTS RECEIVING ANTI RETROVIRAL THERAPY
【24h】

SCREENING OF DRUG RELATED PROBLEMS IN HIV PATIENTS RECEIVING ANTI RETROVIRAL THERAPY

机译:接受抗逆转录病毒治疗的HIV患者的药物相关问题筛查

获取原文
           

摘要

Aim: The main aim of the study is prospective screening of drug related problems in ART receiving patients at RIMS Kadapa. Objectives: The key objectives of the study include To identify various drug related problems using various domains as per PCNE (Pharmaceutical care network Europe). To identify the most common ART regimen causing DRP. Methodology: A prospective observational study conducted for a period of six months november2015-april 2016. The data was collected by using Patient Data Collection Form, PCNE classification V5.01, Drug interaction form, ADR form. The collected data was analysed for age and gender distribution, distribution of patients based on co morbidities, patients with and without DRPs based on type of ART regimen used, distribution of problems, causes for different problems, interventions suggested for different problems then outcome of interventions were calculated. Results: A total of 125 patients 104 members experienced DRPs with ART regimens, which accounts 63(60.57%) males and 41(39.42%) females. Out of 104 patients 59 members experienced DRPs with ZLN regimen. In those patients the main DRPs were adverse drug reactions, drug use problems and drug interactions. The main causes for those problems were Pharmacokinetic problems incl. Ageing/ deterioration in organ function and interactions (C1.4), manifest side effect no other cause (C1.8) as per PCNE scheme V5.01. The various interventions suggested for those problems were Patient (medication) counselling (I2.1), Instructions for use changed to......(I3.4), new drug started(I3.6). the outcomes for suggested interventions were problems( Rashes, muscle pain, vomiting, nausea, headache, cough, abdominal pain.....etc.) totally solved(O1.0) and problems (Neutropenia, anaemia, hyper pigmentation of skin & nails, ear impairment, severe anaemia, finger paralysis, blurred vision.....etc.) were partially solved(O2.0). Conclusion: Our study concludes adverse drug reactions with ART are high in problems domain as per PCNE, which can be decreased by identifying DRPs in early stages of drug therapy, prescribing other drugs cautiously in HIV patients. Majority of DRPs can be decreased by improving patient-physician relationships and patient-pharmacist relationships. For better outcomes patient counselling can be considered as a better interventional tool which will improve adherence and decrease DRPs in HIV patients.
机译:目的:该研究的主要目的是对RIMS Kadapa接受ART的患者进行药物相关问题的前瞻性筛查。目标:该研究的主要目标包括根据PCNE(欧洲药品护理网络)使用各种域来识别各种与药物相关的问题。找出引起DRP的最常见ART方案。方法:2015年11月至2016年4月进行了为期六个月的前瞻性观察性研究。使用患者数据收集表,PCNE分类V5.01,药物相互作用表,ADR表收集数据。分析收集的数据,分析其年龄和性别分布,基于合并症的患者分布,基于使用的ART方案类型的有无DRP的患者,问题的分布,不同问题的原因,针对不同问题建议的干预措施以及干预结果被计算。结果:125位患者共有104位成员接受了抗逆转录病毒疗法的抗逆转录病毒疗法,其中男性63(60.57%)和女性41(39.42%)。在104位患者中,有59位成员经历了ZLN方案的DRP。在这些患者中,主要的DRP是药物不良反应,药物使用问题和药物相互作用。造成这些问题的主要原因是药物动力学问题。根据PCNE方案V5.01,器官功能和相互作用的老化/恶化(C1.4),没有其他原因(C1.8)的副作用。针对这些问题建议的各种干预措施包括患者(药物)咨询(I2.1),使用说明更改为……(I3.4),新药开始(I3.6)。建议采取的干预措施的结果是完全解决(O1.0)的问题(皮疹,肌肉疼痛,呕吐,恶心,头痛,咳嗽,腹痛……等)和问题(中性粒细胞减少,贫血,皮肤色素沉着过多)指甲,耳朵损伤,严重贫血,手指麻痹,视物模糊等)已部分解决(O2.0)。结论:我们的研究得出结论,与PCNE相比,ART的药物不良反应在问题领域中是高发的,可以通过在药物治疗的早期确定DRP并谨慎地在HIV患者中开处方其他药物来减少这种不良反应。可以通过改善患者与医师之间的关系以及患者与药师之间的关系来减少大多数DRP。为了获得更好的结果,可以将患者咨询视为一种更好的干预工具,它将改善HIV患者的依从性并减少DRP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号